Celltrion Receives FDA Approval for Phase 3 Clinical Trial of Keytruda Biosimilar in the U.S. Celltrion announced on the 12th that it has received approval from the U.S. Food and Drug Administration (FDA)… Cheon Okhyeon 2024-08-13